|
시장보고서
상품코드
1747498
울혈성 심부전 시장 : 유형별, 진단별, 성별, 연령층별, 최종사용자별, 지역별Congestive Heart Failure Market, By Type, By Diagnosis, By Gender, By Age Group, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
세계의 울혈성 심부전 시장은 2025년에 249억 5,000만 달러, 2032년에는 408억 5,000만 달러에 이를 것으로 예측되며, 2025-2032년 연평균 복합 성장률(CAGR)은 7.3%를 나타낼 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 | 2024년 | 2025년 시장 규모 | 249억 5,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측 기간(2025-2032년) CAGR | 7.30% | 2032년 가치 예측 | 408억 5,000만 달러 |
세계 울혈성 심부전 시장은 심혈관 질환의 유병률 증가, 노인 인구 증가, 효과적인 치료 옵션에 대한 수요 증가 등으로 인해 최근 몇 년 동안 괄목할 만한 성장세를 보이고 있습니다. 울혈성 심부전(CHF)은 심장이 신체에 필요한 혈액을 충분히 공급하지 못하는 만성 질환입니다. 첨단 진단 기술과 혁신적인 치료법의 등장으로 CHF 관리 시장은 크게 성장하고 있습니다.
시장 역학:.
세계 울혈성 심부전 시장은 심혈관 질환의 유병률 증가, 노인 인구 증가, 좌식 생활습관 증가 등 여러 요인에 의해 주도되고 있습니다. 또한, 울혈성 심부전의 조기 진단 및 치료의 중요성에 대한 인식이 높아지면서 시장 성장에 기여하고 있습니다. 그러나 일부 지역에서는 높은 치료 비용과 불충분한 상환 정책으로 인해 시장 성장이 제한될 수 있습니다. 또한, 사용 가능한 일부 치료 옵션과 관련된 부작용도 시장 성장을 저해하는 요인으로 작용할 수 있습니다. 반면, 유전자 치료, 줄기세포 치료와 같은 새로운 치료법 개발과 개인 맞춤형 의료에 대한 관심이 높아지면서 시장 참여자들에게 큰 성장 기회를 제공합니다. 또한, 신규 치료제 개발을 위한 제약기업과 연구기관의 공동연구 증가도 향후 몇 년간 시장 개척을 촉진할 것으로 예측됩니다.
본 조사의 주요 특징
- 세계의 울혈성 심부전(Congestive Heart Failure) 시장을 상세하게 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 동안 시장 규모(10억 달러)와 연평균 성장률(CAGR)을 조사하여 전해드립니다.
- 또한, 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
- 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 울혈성 심부전 시장의 주요 기업 프로파일을 제공합니다.
- 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 세계 울혈성 심부전 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 업계의 다양한 이해 관계자를 대상으로 합니다.
- 이해관계자들은 세계 울혈성 심부전 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
- 조사 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 발매 및 승인
- PEST 분석
- PORTER 분석
- 인수합병(M&A) 시나리오
- 업계 동향
제4장 세계의 울혈성 심부전 시장, 유형별, 2020년-2032년
- 수축기 심부전
- 확장기 심부전
- 급성 심부전
- 만성 심부전
제5장 세계의 울혈성 심부전 시장, 진단별, 2020년-2032년
- 심장 초음파 검사
- 흉부 X선 검사
- 혈액검사(BNP, NT-proBNP)
- 심장 카테터 검사
- 자공명영상
- 홀터 심전도
- 핵영상
제6장 세계의 울혈성 심부전 시장, 디바이스 유형별, 2020년-2032년
- 페이스메이커
- 삽입형 제세동기(ICD)
- 심장재동기 요법(CRT) 장비
- 심실 보조 장치(VAD)
- 원격 모니터링 장비
- 기타
제7장 세계의 울혈성 심부전 시장, 성별, 2020년-2032년
- 남성
- 여성
제8장 세계의 울혈성 심부전 시장, 연령층별, 2020년-2032년
- 성인
- 소아
- 고령자
제9장 세계의 울혈성 심부전 시장, 최종사용자별, 2020년-2032년
- 병원
- 전문 클리닉
- 외래수술센터(ASC)
- 진단센터
- 재택 헬스케어
- 학술연구기관
제10장 세계의 울혈성 심부전 시장, 지역별, 2020년-2032년
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 남아프리카
- 북아프리카
- 중앙아프리카
제11장 경쟁 구도
- Novartis
- Boehringer Ingelheim
- AstraZeneca
- Johnson & Johnson
- Abbott
- Medtronic
- Boston Scientific
- Pfizer
- Merck & Co
- Bristol Myers Squibb
- LivaNova
- Biotronik
- V-Wave
- Impulse Dynamics
- CVRx
제12장 애널리스트 추천 사항
- 기회
- 애널리스트의 견해
- Coherent Opportunity Map
제13장 참고 문헌과 조사 방법
- 참고 문헌
- 조사 방법
- 출판사에 대해
Global Congestive Heart Failure Market is estimated to be valued at USD 24.95 Bn in 2025 and is expected to reach USD 40.85 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 24.95 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 7.30% | 2032 Value Projection: | USD 40.85 Bn |
The global congestive heart failure market has witnessed significant growth in recent years, driven by the increasing prevalence of cardiovascular diseases, the rising geriatric population, and the growing demand for effective treatment options. Congestive heart failure (CHF) is a chronic condition characterized by the heart's inability to pump sufficient blood to meet the body's needs. With the advent of advanced diagnostic techniques and innovative treatment approaches, the market for CHF management has expanded considerably.
Market Dynamic:
The global congestive heart failure market is driven by several factors, including the rising prevalence of cardiovascular diseases, the growing geriatric population, and the increasing adoption of sedentary lifestyles. The increasing awareness about the importance of early diagnosis and treatment of CHF have also contributed to the market growth. However, the high cost of treatment and the lack of reimbursement policies in some regions may restrain the market growth. Moreover, the side effects associated with some of the available treatment options may also hinder the market growth. On the other hand, the development of novel therapies, such as gene therapy and stem cell therapy, and the increasing focus on personalized medicine offer significant growth opportunities for the market players. Increasing collaborations between pharmaceutical companies and research institutes for the development of novel therapies are also expected to drive the market growth in the coming years.
Key Features of the Study:
- This report provides in-depth analysis of the global congestive heart failure market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global congestive heart failure market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Novartis, Boehringer Ingelheim, AstraZeneca, Johnson & Johnson, Abbott, Medtronic, Boston Scientific, Pfizer, Merck & Co, Bristol Myers Squibb, LivaNova, Biotronik, V-Wave, Impulse Dynamics, and CVRx
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global congestive heart failure market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global congestive heart failure market
Market Segmentation
- Type Insights (Revenue, USD Bn, 2020 - 2032)
- Systolic Heart Failure
- Diastolic Heart Failure
- Acute Heart Failure
- Chronic Heart Failure
- Diagnosis Insights (Revenue, USD Bn, 2020 - 2032)
- Echocardiography
- Chest X-Ray
- Blood Tests (BNP, NT-proBNP)
- Cardiac Catheterization
- Magnetic Resonance Imaging
- Holter Monitoring
- Nuclear Imaging
- Device Type Insights (Revenue, USD Bn, 2020 - 2032)
- Pacemakers
- Implantable Cardioverter-Defibrillators (ICDs)
- Cardiac Resynchronization Therapy (CRT) Devices
- Ventricular Assist Devices (VADs)
- Remote Monitoring Devices
- Others
- Gender Insights (Revenue, USD Bn, 2020 - 2032)
- Male
- Female
- Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Adult
- Pediatrics
- Geriatric
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Diagnostic Centers
- Home Healthcare
- Academic and Research Institutes
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Novartis
- Boehringer Ingelheim
- AstraZeneca
- Johnson & Johnson
- Abbott
- Medtronic
- Boston Scientific
- Pfizer
- Merck & Co
- Bristol Myers Squibb
- LivaNova
- Biotronik
- V-Wave
- Impulse Dynamics
- CVRx
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Congestive Heart Failure Market, By Type
- Global Congestive Heart Failure Market, By Diagnosis
- Global Congestive Heart Failure Market, By Device Type
- Global Congestive Heart Failure Market, By Gender
- Global Congestive Heart Failure Market, By Age Group
- Global Congestive Heart Failure Market, By End User
- Global Congestive Heart Failure Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Congestive Heart Failure Market, By Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Systolic Heart Failure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Diastolic Heart Failure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Acute Heart Failure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Chronic Heart Failure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Congestive Heart Failure Market, By Diagnosis, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Echocardiography
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Chest X-Ray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Blood Tests (BNP, NT-proBNP)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cardiac Catheterization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Magnetic Resonance Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Holter Monitoring
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Nuclear Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Congestive Heart Failure Market, By Device Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pacemakers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Implantable Cardioverter-Defibrillators (ICDs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cardiac Resynchronization Therapy (CRT) Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ventricular Assist Devices (VADs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Remote Monitoring Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Congestive Heart Failure Market, By Gender, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Congestive Heart Failure Market, By Age Group, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Pediatrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Congestive Heart Failure Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Home Healthcare
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Congestive Heart Failure Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Novartis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boehringer Ingelheim
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boston Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- LivaNova
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biotronik
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- V-Wave
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Impulse Dynamics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- CVRx
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
